TRILLIUM THERAPEUTICS INC. Forms 3, 4 and 5: Preferred Stock

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2021-11-17: Reporting owner Walker Paul Edward; Form 4; Security Series II Non-Voting Convertible First Preferred Shares; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
2021-11-17: Reporting owner Walker Paul Edward; Form 4; Security Warrant to Purchase Series II Preferred Shares; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
2021-01-04: Reporting owner Walker Paul Edward; Form 3; Security Series II Non-Voting Convertible First Preferred Shares; Transaction Holding.
2021-01-04: Reporting owner Walker Paul Edward; Form 3; Security Warrant to Purchase Series II Preferred Shares; Transaction Holding.

All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
2021-11-17	Walker Paul Edward Director	4	Series II Non-Voting Convertible First Preferred Shares Derivative · Indirect · (m)	D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)	−6,750,000 0 owned after	$0.00	2021-11-19
2021-11-17	Walker Paul Edward Director	4	Warrant to Purchase Series II Preferred Shares Derivative · Indirect · (m)	D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)	−5,400,000 0 owned after	$0.96 exercise price	2021-11-19
2021-01-04 holding as of filing	Walker Paul Edward Director	3	Series II Non-Voting Convertible First Preferred Shares Derivative · Indirect · (m)	Holding		no price filed	2021-01-04
2021-01-04 holding as of filing	Walker Paul Edward Director	3	Warrant to Purchase Series II Preferred Shares Derivative · Indirect · (m)	Holding		$0.96 exercise price	2021-01-04